Harvard
Hetland, ML
, Christensen, IJ, Tarp, U
, Dreyer, L, Hansen, A, Hansen, IT
, Kollerup, GB, Linde, L, Lindegaard, HM, Poulsen, UE, Schlemmer, A
, Jensen, DV, Jensen, S, Hostenkamp, G
, Østergaard, M & All Departments of Rheumatology in Denmark 2010, '
Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry'
Arthritis & Rheumatism, vol. 62, no. 1, pp. 22-32.
https://doi.org/10.1002/art.27227APA
Hetland, M. L.
, Christensen, I. J., Tarp, U.
, Dreyer, L., Hansen, A., Hansen, I. T., ... All Departments of Rheumatology in Denmark (2010).
Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry.
Arthritis & Rheumatism,
62(1), 22-32.
https://doi.org/10.1002/art.27227CBE
Hetland ML
, Christensen IJ, Tarp U
, Dreyer L, Hansen A, Hansen IT
, Kollerup GB, Linde L, Lindegaard HM, Poulsen UE, Schlemmer A
, Jensen DV, Jensen S, Hostenkamp G
, Østergaard M, All Departments of Rheumatology in Denmark. 2010.
Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry.
Arthritis & Rheumatism. 62(1):22-32.
https://doi.org/10.1002/art.27227MLA
Vancouver
Author
Hetland, Merete Lund
; Christensen, Ib Jarle ; Tarp, Ulrik
; Dreyer, Lene ; Hansen, Annette ; Hansen, Ib Tønder
; Kollerup, Gina Birgitte ; Linde, Louise ; Lindegaard, Hanne Merete ; Poulsen, Uta Engling ; Schlemmer, Annette
; Jensen, Dorte Vendelbo ; Jensen, Signe ; Hostenkamp, Gisela
; Østergaard, Mikkel ; All Departments of Rheumatology in Denmark. /
Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry. In:
Arthritis & Rheumatism. 2010 ; Vol. 62, No. 1. pp. 22-32.
Bibtex
@article{56c03c229cb24ef087ff5b0021eff39e,
title = "Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry",
abstract = "To compare tumor necrosis factor alpha inhibitors directly regarding the rates of treatment response, remission, and the drug survival rate in patients with rheumatoid arthritis (RA), and to identify clinical prognostic factors for response.",
author = "Hetland, {Merete Lund} and Christensen, {Ib Jarle} and Ulrik Tarp and Lene Dreyer and Annette Hansen and Hansen, {Ib T{\o}nder} and Kollerup, {Gina Birgitte} and Louise Linde and Lindegaard, {Hanne Merete} and Poulsen, {Uta Engling} and Annette Schlemmer and Jensen, {Dorte Vendelbo} and Signe Jensen and Gisela Hostenkamp and Mikkel {\O}stergaard and {All Departments of Rheumatology in Denmark}",
year = "2010",
month = "1",
day = "1",
doi = "10.1002/art.27227",
language = "English",
volume = "62",
pages = "22--32",
journal = "Arthritis and Rheumatism",
issn = "0004-3591",
publisher = "John/Wiley & Sons, Inc. John/Wiley & Sons Ltd",
number = "1",
}
RIS
TY - JOUR
T1 - Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry
AU - Hetland, Merete Lund
AU - Christensen, Ib Jarle
AU - Tarp, Ulrik
AU - Dreyer, Lene
AU - Hansen, Annette
AU - Hansen, Ib Tønder
AU - Kollerup, Gina Birgitte
AU - Linde, Louise
AU - Lindegaard, Hanne Merete
AU - Poulsen, Uta Engling
AU - Schlemmer, Annette
AU - Jensen, Dorte Vendelbo
AU - Jensen, Signe
AU - Hostenkamp, Gisela
AU - Østergaard, Mikkel
AU - All Departments of Rheumatology in Denmark
PY - 2010/1/1
Y1 - 2010/1/1
N2 - To compare tumor necrosis factor alpha inhibitors directly regarding the rates of treatment response, remission, and the drug survival rate in patients with rheumatoid arthritis (RA), and to identify clinical prognostic factors for response.
AB - To compare tumor necrosis factor alpha inhibitors directly regarding the rates of treatment response, remission, and the drug survival rate in patients with rheumatoid arthritis (RA), and to identify clinical prognostic factors for response.
U2 - 10.1002/art.27227
DO - 10.1002/art.27227
M3 - Journal article
VL - 62
SP - 22
EP - 32
JO - Arthritis and Rheumatism
JF - Arthritis and Rheumatism
SN - 0004-3591
IS - 1
ER -
